You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR COLAZAL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for COLAZAL

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00618202 ↗	A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions	Completed	Roxane Laboratories	N/A	2005-05-01	The objective of this study was to assess the bioequivalence of a potential generic 750 mg balsalazide disodium capsule formulation compared with Salix Pharmaceutical's 750 mg balsalazide disodium capsule, Colazal, following a single 750 mg dose, administered under fasting conditions.
NCT00618228 ↗	Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions	Completed	Roxane Laboratories	N/A	2004-01-01	The objective of this study was to assess bioequivalence of a potential generic 750 mg balsalazide disodium capsule formulation compared with Salix Pharmaceutical's 750 mg balsalazide disodium capsule, Colazal, following a single 750 mg dose, under fasting conditions.
NCT00648531 ↗	Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg	Completed	Mylan Pharmaceuticals	Phase 1	2004-05-01	The objective of this study was to investigate the bioequivalence of Mylan balsalazide disodium 750 mg capsules and Salix Colazal® 750 mg capsules following a single, oral 2250 mg (3 x 750 mg) dose administration under fasting conditions.
NCT00649480 ↗	Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg	Completed	Mylan Pharmaceuticals	Phase 1	2007-01-01	The objective of this study was to investigate the bioequivalence of Mylan balsalazide disodium 750 mg capsules to Salix Colazal® 750 mg capsules following a single, oral 2250 mg (3 x 750 mg) dose administration under fed conditions.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for COLAZAL

Condition Name

Chart
Table

Condition Name for COLAZAL
Intervention	Trials
Healthy	2
Ulcerative Colitis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for COLAZAL
Intervention	Trials
Colitis, Ulcerative	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for COLAZAL

Trials by Country

Map
Table

Trials by Country for COLAZAL
Location	Trials
United States	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for COLAZAL
Location	Trials
North Dakota	2
Texas	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for COLAZAL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for COLAZAL
Clinical Trial Phase	Trials
Phase 1	2
N/A	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for COLAZAL
Clinical Trial Phase	Trials
Completed	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for COLAZAL

Sponsor Name

Chart
Table

Sponsor Name for COLAZAL
Sponsor	Trials
Roxane Laboratories	2
Mylan Pharmaceuticals	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for COLAZAL
Sponsor	Trials
Industry	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.